Xilio Research Development from 2010 to 2026
| XLO Stock | USD 0.59 0.01 1.67% |
Research Development | First Reported 2020-03-31 | Previous Quarter 15.3 M | Current Value 14.3 M | Quarterly Volatility 3.2 M |
Check Xilio Development financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xilio Development's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 85.5 K or Selling General Administrative of 22.2 M, as well as many indicators such as Price To Sales Ratio of 6.45, Dividend Yield of 0.0 or PTB Ratio of 3.17. Xilio financial statements analysis is a perfect complement when working with Xilio Development Valuation or Volatility modules.
Xilio | Research Development | Build AI portfolio with Xilio Stock |
Evaluating Xilio Development's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Xilio Development's fundamental strength.
Latest Xilio Development's Research Development Growth Pattern
Below is the plot of the Research Development of Xilio Development over the last few years. It is Xilio Development's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xilio Development's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Xilio Research Development Regression Statistics
| Arithmetic Mean | 28,565,530 | |
| Geometric Mean | 23,644,075 | |
| Coefficient Of Variation | 63.00 | |
| Mean Deviation | 16,834,742 | |
| Median | 14,256,000 | |
| Standard Deviation | 17,995,866 | |
| Sample Variance | 323.9T | |
| Range | 44.9M | |
| R-Value | 0.83 | |
| Mean Square Error | 109T | |
| R-Squared | 0.68 | |
| Significance | 0.000042 | |
| Slope | 2,948,641 | |
| Total Sum of Squares | 5181.6T |
Xilio Research Development History
About Xilio Development Financial Statements
Xilio Development investors utilize fundamental indicators, such as Research Development, to predict how Xilio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Research Development | 47.4 M | 48 M |
Pair Trading with Xilio Development
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xilio Development position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will appreciate offsetting losses from the drop in the long position's value.Moving together with Xilio Stock
| 0.81 | EVGN | Evogene | PairCorr |
| 0.71 | IMNN | Imunon Inc | PairCorr |
| 0.61 | IPHA | Innate Pharma | PairCorr |
| 0.82 | LYRA | Lyra Therapeutics | PairCorr |
| 0.84 | MBIO | Mustang Bio | PairCorr |
Moving against Xilio Stock
| 0.83 | ARWR | Arrowhead Pharmaceuticals | PairCorr |
| 0.75 | MRKR | Marker Therapeutics | PairCorr |
| 0.72 | CING | Cingulate | PairCorr |
| 0.57 | AEON | AEON Biopharma | PairCorr |
| 0.51 | BOLT | Bolt Biotherapeutics | PairCorr |
The ability to find closely correlated positions to Xilio Development could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xilio Development when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xilio Development - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xilio Development to buy it.
The correlation of Xilio Development is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xilio Development moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xilio Development moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xilio Development can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Xilio Development Correlation against competitors. To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Will Biotechnology sector continue expanding? Could Xilio diversify its offerings? Factors like these will boost the valuation of Xilio Development. Anticipated expansion of Xilio directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Xilio Development data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.61) | Revenue Per Share | Quarterly Revenue Growth 7.425 | Return On Assets | Return On Equity |
The market value of Xilio Development is measured differently than its book value, which is the value of Xilio that is recorded on the company's balance sheet. Investors also form their own opinion of Xilio Development's value that differs from its market value or its book value, called intrinsic value, which is Xilio Development's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Xilio Development's market value can be influenced by many factors that don't directly affect Xilio Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xilio Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xilio Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Xilio Development's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.